Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Richtig, G; Ehall, B; Richtig, E; Aigelsreiter, A; Gutschner, T; Pichler, M.
Function and Clinical Implications of Long Non-Coding RNAs in Melanoma.
Int J Mol Sci. 2017; 18(4):
Doi: 10.3390/ijms18040715
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Pichler Martin
-
Richtig Georg
- Co-Autor*innen der Med Uni Graz
-
Aigelsreiter Ariane
-
Ehall Barbara
-
Richtig Erika
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Metastatic melanoma is the most deadly type of skin cancer. Despite the success of immunotherapy and targeted agents, the majority of patients experience disease recurrence upon treatment and die due to their disease. Long non-coding RNAs (lncRNAs) are a new subclass of non-protein coding RNAs involved in (epigenetic) regulation of cell growth, invasion, and other important cellular functions. Consequently, recent research activities focused on the discovery of these lncRNAs in a broad spectrum of human diseases, especially cancer. Additional efforts have been undertaken to dissect the underlying molecular mechanisms employed by lncRNAs. In this review, we will summarize the growing evidence of deregulated lncRNA expression in melanoma, which is linked to tumor growth and progression. Moreover, we will highlight specific molecular pathways and modes of action for some well-studied lncRNAs and discuss their potential clinical implications.
- Find related publications in this database (using NLM MeSH Indexing)
-
Biomarkers, Tumor - genetics
-
Cell Proliferation -
-
Disease Progression -
-
Gene Expression Regulation, Neoplastic -
-
Humans -
-
Melanoma - genetics
-
Melanoma - pathology
-
Neoplasm Metastasis -
-
RNA, Long Noncoding - genetics
- Find related publications in this database (Keywords)
-
lncRNA
-
skin cancer